Loading clinical trials...
Loading clinical trials...
Hypertrophic cardiomyopathy (HCM) is a frequent cardiac pathology with an estimated prevalence of 1/500 in France. The main risk factor for sudden death in this pathology is the presence and extent of...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
NCT05987124 · Sinusoidal Obstruction Syndrome, Veno-occlusive Disease
NCT07531810 · Nasal Deformity, Rhinoplasty, and more
NCT05169398 · Malignant Biliary Obstruction
NCT05836259 · Hypertrophic Cardiomyopathy
NCT07054073 · Hypertrophic Cardiomyopathy (HCM)
CHU Amiens
Amiens
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions